The same total apoC-III/apoC-II ratios between the subgroups of obese patients suggest that this parallel increase in apoproteins having opposite functional effects in the TRL clearing process is most likely secondary to the increase of plasma TRL, as we have previously reported for type 2 diabetic patients [18]. The gene discussed is APOC2; the disease is type 2 diabetes mellitus.